+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biosurgery Market 2020-2024

  • ID: 5004417
  • Report
  • January 2020
  • Region: Global
  • 162 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • CSL Ltd.
  • Dickinson and Co.
  • Getinge AB
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Biosurgery Market 2020-2024.

The publisher has been monitoring the global biosurgery market and it is poised to grow by USD 4.81 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report on the global biosurgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of surgical procedures. In addition, constant technological advances is anticipated to boost the growth of the global biosurgery market as well.

Market Segmentation

The global biosurgery market is segmented as below:

Product:
  • Soft-tissue Attachments
  • Hemostatic Agents
  • Bone Graft Substitutes
  • Surgical Sealants
  • Adhesives
  • Adhesion Barriers

Geographic Segmentation:
  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global biosurgery market growth

This study identifies constant technological advances as the prime reasons driving the global biosurgery market growth during the next few years.

Prominent vendors in global biosurgery market

The publisher a detailed analysis of around 25 vendors operating in the global biosurgery market , including some of the vendors such as B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CSL Ltd., Getinge AB, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc. and Stryker Corp. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • CSL Ltd.
  • Dickinson and Co.
  • Getinge AB

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Value Chain Analysis
  • Market segmentation analysis

PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Soft-tissue attachments - Market size and forecast 2019-2024
  • Hemostatic agents - Market size and forecast 2019-2024
  • Bone graft substitutes - Market size and forecast 2019-2024
  • Surgical sealants and adhesives - Market size and forecast 2019-2024
  • Adhesion barriers - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS
  • Technological advances
  • Enhanced pipeline products
  • Funding for the development of innovative products

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Co.
  • CSL Ltd.
  • Getinge AB
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson
  • Medtronic Plc
  • Pfizer Inc.
  • Stryker Corp.

PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits
Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Soft-tissue attachments - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Soft-tissue attachments - Year-over-year growth 2020-2024 (%)
Exhibit 22: Hemostatic agents - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Hemostatic agents - Year-over-year growth 2020-2024 (%)
Exhibit 24: Bone graft substitutes - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Bone graft substitutes - Year-over-year growth 2020-2024 (%)
Exhibit 26: Surgical sealants and adhesives - Market size and forecast 2019-2024 ($ millions)
Exhibit 27: Surgical sealants and adhesives - Year-over-year growth 2020-2024 (%)
Exhibit 28: Adhesion barriers - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: Adhesion barriers - Year-over-year growth 2020-2024 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Market share by geography 2019-2024 (%)
Exhibit 33: Geographic comparison
Exhibit 34: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Number of surgical procedures in 2014: US
Exhibit 36: US: percentage of surgical visits in ambulatory and inpatient settings (2014)
Exhibit 37: North America - Year-over-year growth 2020-2024 (%)
Exhibit 38: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 39: Europe: Surgical procedures related to circulatory system diseases (2017)
Exhibit 40: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 41: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 42: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 43: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 44: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 45: Key leading countries
Exhibit 46: Market opportunity
Exhibit 47: US: Inpatient stays in 2014 for operating room procedures for cardiovascular and orthopedic related disorders
Exhibit 48: Product launch details and market impact analysis
Exhibit 49: Acquisitions and their market impact analysis
Exhibit 50: Product recalls
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Vendor landscape
Exhibit 53: Landscape disruption
Exhibit 54: Vendors covered
Exhibit 55: Vendor classification
Exhibit 56: Market positioning of vendors
Exhibit 57: B. Braun Melsungen AG - Vendor overview
Exhibit 58: B. Braun Melsungen AG - Business segments
Exhibit 59: B. Braun Melsungen AG - Organizational developments
Exhibit 60: B. Braun Melsungen AG - Geographic focus
Exhibit 61: B. Braun Melsungen AG - Segment focus
Exhibit 62: B. Braun Melsungen AG - Key offerings
Exhibit 63: B. Braun Melsungen AG - Key customers
Exhibit 64: Baxter International Inc. - Vendor overview
Exhibit 65: Baxter International Inc. - Product segments
Exhibit 66: Baxter International Inc. - Organizational developments
Exhibit 67: Baxter International Inc. - Geographic focus
Exhibit 68: Baxter International Inc. - Segment focus
Exhibit 69: Baxter International Inc. - Key offerings
Exhibit 70: Baxter International Inc. - Key customers
Exhibit 71: Becton, Dickinson and Co. - Vendor overview
Exhibit 72: Becton, Dickinson and Co. - Business segments
Exhibit 73: Becton, Dickinson and Co. - Organizational developments
Exhibit 74: Becton, Dickinson and Co. - Geographic focus
Exhibit 75: Becton, Dickinson and Co. - Segment focus
Exhibit 76: Becton, Dickinson and Co. - Key offerings
Exhibit 77: Becton, Dickinson and Co. - Key customers
Exhibit 78: CSL Ltd. - Vendor overview
Exhibit 79: CSL Ltd. - Business segments
Exhibit 80: CSL Ltd. - Organizational developments
Exhibit 81: CSL Ltd. - Geographic focus
Exhibit 82: CSL Ltd. - Segment focus
Exhibit 83: CSL Ltd. - Key offerings
Exhibit 84: CSL Ltd. - Key customers
Exhibit 85: Getinge AB - Vendor overview
Exhibit 86: Getinge AB - Business segments
Exhibit 87: Getinge AB - Organizational developments
Exhibit 88: Getinge AB - Geographic focus
Exhibit 89: Getinge AB - Segment focus
Exhibit 90: Getinge AB - Key offerings
Exhibit 91: Getinge AB - Key customers
Exhibit 92: Integra LifeSciences Holdings Corp. - Vendor overview
Exhibit 93: Integra LifeSciences Holdings Corp. - Business segments
Exhibit 94: Integra LifeSciences Holdings Corp. - Organizational developments
Exhibit 95: Integra LifeSciences Holdings Corp. - Geographic focus
Exhibit 96: Integra LifeSciences Holdings Corp. - Segment focus
Exhibit 97: Integra LifeSciences Holdings Corp. - Key offerings
Exhibit 98: Integra LifeSciences Holdings Corp. - Key customers
Exhibit 99: Johnson & Johnson - Vendor overview
Exhibit 100: Johnson & Johnson - Business segments
Exhibit 101: Johnson & Johnson - Organizational developments
Exhibit 102: Johnson & Johnson - Geographic focus
Exhibit 103: Johnson & Johnson - Segment focus
Exhibit 104: Johnson & Johnson - Key offerings
Exhibit 105: Johnson & Johnson - Key customers
Exhibit 106: Medtronic Plc - Vendor overview
Exhibit 107: Medtronic Plc - Business segments
Exhibit 108: Medtronic Plc - Organizational developments
Exhibit 109: Medtronic Plc - Geographic focus
Exhibit 110: Medtronic Plc - Segment focus
Exhibit 111: Medtronic Plc - Key offerings
Exhibit 112: Medtronic Plc - Key customers
Exhibit 113: Pfizer Inc. - Vendor overview
Exhibit 114: Pfizer Inc. - Business segments
Exhibit 115: Pfizer Inc. - Organizational developments
Exhibit 116: Pfizer Inc. - Geographic focus
Exhibit 117: Pfizer Inc. - Segment focus
Exhibit 118: Pfizer Inc. - Key offerings
Exhibit 119: Pfizer Inc. - Key customers
Exhibit 120: Stryker Corp. - Vendor overview
Exhibit 121: Stryker Corp. - Business segments
Exhibit 122: Stryker Corp. - Organizational developments
Exhibit 123: Stryker Corp. - Geographic focus
Exhibit 124: Stryker Corp. - Segment focus
Exhibit 125: Stryker Corp. - Key offerings
Exhibit 126: Stryker Corp. - Key customers
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Definition of market positioning of vendors
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • CSL Ltd.
  • Dickinson and Co.
  • Getinge AB
The publisher recognizes the following companies as the key players in the global biosurgery market : B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CSL Ltd., Getinge AB, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Plc, Pfizer Inc. and Stryker Corp. .

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the constant technological advances."

According to the report, one of the major drivers for this market is the increasing number of surgical procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton
  • Dickinson and Co.
  • CSL Ltd.
  • Getinge AB
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson
  • Medtronic Plc
  • Pfizer Inc.
  • Stryker Corp.
Note: Product cover images may vary from those shown